Nebius Group: Boynton trust proposes 333-share sale
Four earlier trust sales, dated August 14 through October 15, 2026, are labeled 10b5-1 sales.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Nebius Group N.V. (NBIS) is identified as the issuer in a notice listing a proposed sale by The John W. Boynton IV Trust of 2006 of 333 common shares through Morgan Stanley Smith Barney LLC. The stated approximate aggregate market value is $60,719.22, and the approximate sale date is October 29, 2026. The notice also lists earlier sales by the trust as 10b5-1 sales: 7,260 shares on October 15, 2026; 50 shares on September 29, 2026; 6,364 shares on September 15, 2026; and 5,296 shares on August 14, 2026. John W. Boyton is listed as a Director and signed the notice.
Key Figures
Key Terms
Rule 144 regulatory
Restricted Stock Units financial
10b5-1 Sales regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What earlier NBIS sales did the trust report?
AI-generated analysis. How Rhea-AI works. Not financial advice.